Pharma & Health News Top Stories Today – HealthWHO, CDC release joint report on 2021 measles vaccine coverage 24/11/2022The report highlights the long-term trend and the power of vaccines to save lives. Mortality has decreased by 83 per cent during the period 2000–2021 (from 761,000 to 128,000 deaths annually), with an estimated 56 million measles deaths averted by vaccination.Experts deliberate the role of digitisation in healthcare delivery ecosystem 24/11/2022The second edition of Economic Times Healthcare Leaders Summit 2022 hosted a Tech Leaders Session on ‘Digital Health: Role of Tech & AI Leaders’. The discussion highlighted the challenges and opportunities in the transformation of healthcare and protecting patient privacy and data protection in the era of digital health.Eli Lilly introduces medication for early stage breast cancer 24/11/2022The company has introduced Ramiven in strengths of 50 mg, 100 mg, 150 mg and 200 mg, for treating early breast cancer (EBC).COVID-19: Active cases in India down to 5,881 24/11/2022The active cases constitute 0.01 per cent of the total infections, while the national COVID-19 recovery rate has increased to 98.80 per cent, according to the health ministry website.Proactive approach and empowerment of healthcare workers can help tackle future adversities 24/11/2022Healthcare workers need to be empowered and trained such that they can act independently and take informed decisions in times of urgency, keeping all financial, operational, and medical verticals in mind, informed healthcare experts at the second edition of the Economic Times Healthcare Leaders Summit 2022 organised by ETHealthworld.Diagnostics experts call on the need for patient-centric health ecosystem 23/11/2022The panel discussion on ‘Roadmap of the Healthcare and Diagnostics Sector - Disruption or Value Creation’ deliberated on the vital role of technology in diagnostics and how the sector is evolving. The panelists commented on the rise of integrated healthcare, the global healthcare market and the growing need for healthcare providers to meet patient-centric demands.Study explains breast cancer protein can predict effectiveness of DNA-damaging therapies 23/11/2022Researchers have discovered a protein that can predict whether or not DNA-damaging treatments will be effective when it is found in high concentrations in breast cancer tumours.Takeda’s BLA for ‘TAK-003’, dengue vaccine candidate gets priority review by FDA 23/11/2022The TAK-003 BLA is supported by safety and efficacy data from the pivotal Phase 3 Tetravalent Immunisation against Dengue Efficacy Study (TIDES) trial, where the dengue vaccine candidate met its primary endpoint by preventing 80.2 per cent of symptomatic dengue cases at 12 months.50% of lung cancer patients since 2012 are non-smokers: Medanta 23/11/2022Earlier, 10-20 per cent of lung cancer patients were non-smokers, the doctors who carried out the study said. They also said their analysis involving 304 patients at the hospital’s OPD between March 2012 and November 2022 indicates that the risk group for lung cancer has expanded from the dominant at-risk demographic of older adults who […]India's Pharma exports grow by 138 pc since 2013-14 23/11/2022Building on the outstanding performance in the previous FY 2020-21, Indian pharma exports once again registered a healthy performance in 2021-22. The pharma exports in 2021-22 sustained positive growth despite the global trade disruptions and drop in demand for COVID-related medicines. In May, Indian pharma companies enabled by their price competitiveness and good quality, made […] Pharma & Health NewsUSFDA designates Cipla's Goa plant as 'Official Action Indicated' 24/11/2022Cipla states that an FDA inspection revealed significant objectionable conditions or practices and action must be taken to address the issues.Eli Lilly introduces medication for early stage breast cancer 24/11/2022The company has introduced Ramiven in strengths of 50 mg, 100 mg, 150 mg and 200 mg, for treating early breast cancer (EBC).SK Bioscience suspends production of COVID-19 vaccine 'Sky Covione' 24/11/2022Vaccines are produced by dividing into undiluted solutions and finished products, and finished products are supplied according to market demand. Sky Covione is not currently being produced due to the low vaccination rate, and we will resume production when there is a request from the government said SK Bioscience offical.South Africa's Biovac in new oral cholera vaccine deal 23/11/2022The partnership with non-profit IVI, headquartered in South Korea, aims to boost output and reduce vaccine shortages amid a spate of global outbreaks that spurred the World Health Organization (WHO) to temporarily change its dosage regime.Takeda’s BLA for ‘TAK-003’, dengue vaccine candidate gets priority review by FDA 23/11/2022The TAK-003 BLA is supported by safety and efficacy data from the pivotal Phase 3 Tetravalent Immunisation against Dengue Efficacy Study (TIDES) trial, where the dengue vaccine candidate met its primary endpoint by preventing 80.2 per cent of symptomatic dengue cases at 12 months.Aurobindo unit, Evive Biotech ink licensing pact to commercialise CIN treatment product in US 23/11/2022In addition to the US health regulator, Evive's Marketing Authorization Application (MAA), and New Drug Application (NDA) for Ryzneuta are currently under review by European and Chinese regulators.India's Pharma exports grow by 138 pc since 2013-14 23/11/2022Building on the outstanding performance in the previous FY 2020-21, Indian pharma exports once again registered a healthy performance in 2021-22. The pharma exports in 2021-22 sustained positive growth despite the global trade disruptions and drop in demand for COVID-related medicines. In May, Indian pharma companies enabled by their price competitiveness and good quality, made […]Gavi rejects Novavax's claim on COVID vaccine deal breach 23/11/2022More than 18 months after signing the agreement, Novavax has not been able to make a single dose available to COVAX from the contractually stipulated sites to-date, Gavi said.CPhI & P-MEC India expo to encourage cost-effective solutions 23/11/202215th edition of CPhI & P-MEC India Expo to be held from 29th November-1st December 2022, at the India Expo Centre, Greater Noida, Delhi-NCR. The show will be a part of the India Pharma Week, a marquee celebration catering to every need of the pharma community attendees. The shows will bring together over 1500 exhibitors […]Antitrust litigation filed against Dr Reddy's Laboratories, other generic pharma companies in US 22/11/2022The complaint, which purports to be on behalf of a class of indirect purchasers, asserts claims under federal and state antitrust laws and other state laws alleging that the defendants improperly restrained competition and maintained a shared monopoly in the sale of brand and generic Revlimid through their respective settlements of patent litigation: Dr Reddy's […]GSK to stop selling blood cancer drug Blenrep in United States 22/11/2022GSK said access to Blenrep in other countries where it is marketed is unaffected, including across the European Union. The company is still discussing the latest clinical data with EU health authorities, a GSK official said.Lumos Pharma’s LUM-201 to potentially improve compliance in PGHD: GlobalData 22/11/2022In the Phase II trials, the safety and tolerability of LUM-201 were found to be comparable to recombinant human Growth Hormone (rhGH) and the growth response observed was in line with expectations based on comparisons with historical data from rhGH trials.Glenmark Pharma reaches settlement agreement with Pfizer for Axitinib tablets 22/11/2022Glenmark had received tentative approval by the USFDA for their generic Axitinib tablets, 1 mg and 5 mg on November 30, 2020.Teva hires ex-Novartis executive to succeed CEO Schultz 22/11/2022Richard Francis, who currently holds the top post at gene therapy firm Purespring Therapeutics and biopharma company Forcefield Therapeutics, will also take the role of Teva's president, effective Jan. 1, 2023.Novavax ends COVID vaccine sale agreement with Gavi 22/11/2022The company cited Gavi's failure to procure the 350 million doses it had agreed to buy in May last year for the COVAX facility.Alembic Pharmaceuticals gets final USFDA approval for Nifedipine extended-release tablets 21/11/2022Nifedipine extended-release tablets are indicated for the management of vasospastic angina, chronic stable angina and hypertension.Mumbai: GSK Pharma shuts its consumer trade channel 19/11/2022An industry expert explained that their role was taking orders from chemists which in today’s world can be done more effectively through the digital medium. They would ensure brands are present in the chemist and retail outlets.Provention Bio diabetes drug to cost $13,850/vial 19/11/2022The U.S. Food and Drug Administration approved the use of the drug, to be sold under the brand name Tzield, late on Thursday for delaying the onset of insulin-dependent type 1 diabetes, which is less common than type 2 of the disease, for people aged 8 years and above.Pfizer/BioNTech Omicron shot shows immune response against BQ.1.1 subvariant 18/11/2022Antibody levels against the variant rose nearly 9 times in older adults, aged 55 and above, who received the Omicron shot compared to a 2-fold increase in participants with the original shot, according to data posted on the online archive bioRxiv.Strides Pharma arms gets USFDA approval for potassium-deficiency drug 18/11/2022The product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), potassium chloride oral solution USP, 40 mEq/15 mL (20 per cent) of Genus Lifesciences Inc. WHO newsSuspension of supply of COVID-19 vaccine (COVAXIN®) 04/04/2022Suspension of supply of Covaxin produced by Bharat, through UN procurement agencies and recommending to countries that received the vaccine to take actions as appropriate.WHO, Qatar, FIFA leaders agree actions to promote health at FIFA World Cup Qatar 2022™ 01/04/2022As part of a unique global partnership to promote health, the senior leadership of the World Health Organization (WHO), the State of Qatar and FIFA today agreed a range of measures that will be implemented at this year’s FIFA World Cup Qatar 2022™ to protect and encourage health; and take lessons learned from the first […]Billions of people still breathe unhealthy air: new WHO data 01/04/2022Almost the entire global population (99%) breathes air that exceeds WHO air quality limits, and threatens their health. A record number of over 6000 cities in 117 countries are now monitoring air quality, but the people living in them are still breathing unhealthy levels of fine particulate matter and nitrogen dioxide, with people in low […]WHO’s training for caregivers of children with autism goes online 30/03/2022In the lead-up to World Autism Awareness Day on 2 April, WHO is releasing an online version of its training programme for caregivers of children with developmental delays or disabilities, including autism. The programme, which has already been piloted in face-to-face format in more than 30 countries, such as Brazil, India, Italy and Kenya, teaches […]Egypt and Nigeria medicines regulators achieve high maturity level in WHO classification and WHO launches list of regulatory authorities that meet international standards 30/03/2022Today, WHO announced that Egypt’s and Nigeria’s medical products regulatory agencies had reached maturity level 3. This means that these national bodies have been found to function well and that they could be eligible for inclusion into the transitional WHO Listed Authorities, a list that will comprise the world’s regulators of reference – that is, […]WHO releases 10-year strategy for genomic surveillance of pathogens 30/03/2022WHO is releasing a strategy to strengthen and scale up genomic surveillance around the world.Historically, few countries have routinely done genomic surveillance in-country, a technology considered complicated and expensive. But COVID-19 changed that. Genomic surveillance is the process of constantly monitoring pathogens and analyzing their genetic similarities and differences. It helps researchers, epidemiologists and public […]European Union funding boosts COVID-19 vaccination in Africa 30/03/2022A contribution of €16 million from the European Commission's Directorate-General for European Civil Protection and Humanitarian Aid Operations (ECHO) will help the World Health Organization (WHO) boost COVID-19 vaccination campaigns and increase coverage in 15 African countries, where only 15 percent of the population is vaccinated.The funding is part of the European Union's (EU) humanitarian […]The Netherlands and WHO: Partners for health and human rights around the world 28/03/2022Minister of Foreign Trade and Development Cooperation of the Netherlands, Ms Liesje Schreinemacher, met for the first time with Dr Tedros Adhanom Ghebreyesus, WHO Director-General in WHO headquarters. The discussions focused on the strategic partnership between WHO and the Netherlands in support of global health security and a healthier world for all.“It was an honor […]WHO urges quality care for women and newborns in critical first weeks after childbirth 28/03/2022Worldwide, more than 3 in 10 women and babies do not currently receive postnatal care in the first days after birth - the period when most maternal and infant deaths occur. Meanwhile the physical and emotional consequences of childbirth – from injuries to recurring pain and trauma - can be debilitating if unmanaged, but are […]WHO establishes the Global Centre for Traditional Medicine in India 25/03/2022The World Health Organization (WHO) and the Government of India today signed an agreement to establish the WHO Global Centre for Traditional Medicine. This global knowledge centre for traditional medicine, supported by an investment of USD 250 million from the Government of India, aims to harness the potential of traditional medicine from across the world […]
English
ગુજરાતી
हिन्दी
മലയാളം
मराठी
தமிழ்
తెలుగు